Skip to content
10-K

Annual Report

MEDINOTEC, INC. MDNC

0001663577-24-000168

← back to feed
Filed
Jul 5, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jun 1, 2024 11.73M sh
Capex FY 2024 · Feb 28, 2023 $55.28K
Operating Cash Flow FY 2024 · Feb 28, 2023 −$490.55K
Current Liabilities FY 2024 · Feb 28, 2023 $71.31K
Total Liabilities FY 2024 · Feb 28, 2023 $1.93M
Current Assets FY 2024 · Feb 28, 2023 $3.37M
Total Assets FY 2024 · Feb 28, 2023 $4.49M
Eps Basic FY 2024 · Feb 28, 2023 −$0.03
Sga Expense restated FY 2024 · Feb 28, 2023 −$648.17K
Rd Expense restated FY 2024 · Feb 28, 2023 −$64.87K
Net Income FY 2024 · Feb 28, 2023 −$352.74K
Operating Income restated FY 2024 · Feb 28, 2023 −$238.59K
Gross Profit FY 2024 · Feb 28, 2023 $581.82K
Cost Of Revenue FY 2024 · Feb 28, 2023 −$417.76K
Revenue FY 2024 · Feb 28, 2023 $999.58K
Cash And Equivalents FY 2024 · Feb 28, 2022 $131.58K
Stockholders Equity FY 2024 · Feb 28, 2022 −$469.99K